
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Chronic Hepatitis B Infection
Lydia Tang, Emily Covert, Eleanor Wilson, et al.
JAMA (2018) Vol. 319, Iss. 17, pp. 1802-1802
Closed Access | Times Cited: 565
Lydia Tang, Emily Covert, Eleanor Wilson, et al.
JAMA (2018) Vol. 319, Iss. 17, pp. 1802-1802
Closed Access | Times Cited: 565
Showing 1-25 of 565 citing articles:
Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection
Xiaoqiang Chai, Longfei Hu, Yan Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 945
Xiaoqiang Chai, Longfei Hu, Yan Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 945
The role of long noncoding RNAs in hepatocellular carcinoma
Zhao Huang, Jiankang Zhou, Yong Peng, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 429
Zhao Huang, Jiankang Zhou, Yong Peng, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 429
Immunobiology and pathogenesis of hepatitis B virus infection
Matteo Iannacone, Luca G. Guidotti
Nature reviews. Immunology (2021) Vol. 22, Iss. 1, pp. 19-32
Closed Access | Times Cited: 344
Matteo Iannacone, Luca G. Guidotti
Nature reviews. Immunology (2021) Vol. 22, Iss. 1, pp. 19-32
Closed Access | Times Cited: 344
KASL clinical practice guidelines for management of chronic hepatitis B
Clinical and Molecular Hepatology (2019) Vol. 25, Iss. 2, pp. 93-159
Open Access | Times Cited: 191
Clinical and Molecular Hepatology (2019) Vol. 25, Iss. 2, pp. 93-159
Open Access | Times Cited: 191
Dual-targeting nanoparticle vaccine elicits a therapeutic antibody response against chronic hepatitis B
Wenjun Wang, Xiaoxiao Zhou, Yingjie Bian, et al.
Nature Nanotechnology (2020) Vol. 15, Iss. 5, pp. 406-416
Open Access | Times Cited: 189
Wenjun Wang, Xiaoxiao Zhou, Yingjie Bian, et al.
Nature Nanotechnology (2020) Vol. 15, Iss. 5, pp. 406-416
Open Access | Times Cited: 189
Hepatitis B virus cccDNA: Formation, regulation and therapeutic potential
Yuchen Xia, Haitao Guo
Antiviral Research (2020) Vol. 180, pp. 104824-104824
Open Access | Times Cited: 144
Yuchen Xia, Haitao Guo
Antiviral Research (2020) Vol. 180, pp. 104824-104824
Open Access | Times Cited: 144
Interferon and Hepatitis B: Current and Future Perspectives
Jianyu Ye, Jieliang Chen
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 129
Jianyu Ye, Jieliang Chen
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 129
KASL clinical practice guidelines for management of chronic hepatitis B
Clinical and Molecular Hepatology (2022) Vol. 28, Iss. 2, pp. 276-331
Open Access | Times Cited: 88
Clinical and Molecular Hepatology (2022) Vol. 28, Iss. 2, pp. 276-331
Open Access | Times Cited: 88
Hepatitis Virus and Hepatocellular Carcinoma: Recent Advances
Chen Shen, Xin Jiang, Mei Li, et al.
Cancers (2023) Vol. 15, Iss. 2, pp. 533-533
Open Access | Times Cited: 80
Chen Shen, Xin Jiang, Mei Li, et al.
Cancers (2023) Vol. 15, Iss. 2, pp. 533-533
Open Access | Times Cited: 80
Periodontitis, chronic liver diseases, and the emerging oral‐gut‐liver axis
Emmanuel Albuquerque‐Souza, Sinem E. Sahingur
Periodontology 2000 (2022) Vol. 89, Iss. 1, pp. 125-141
Open Access | Times Cited: 77
Emmanuel Albuquerque‐Souza, Sinem E. Sahingur
Periodontology 2000 (2022) Vol. 89, Iss. 1, pp. 125-141
Open Access | Times Cited: 77
Changing prevalence of chronic hepatitis B virus infection in China between 1973 and 2021: a systematic literature review and meta-analysis of 3740 studies and 231 million people
Zhenqiu Liu, Chunqing Lin, Xianhua Mao, et al.
Gut (2023) Vol. 72, Iss. 12, pp. 2354-2363
Open Access | Times Cited: 57
Zhenqiu Liu, Chunqing Lin, Xianhua Mao, et al.
Gut (2023) Vol. 72, Iss. 12, pp. 2354-2363
Open Access | Times Cited: 57
Construction of a diagnostic model for hepatitis B-related hepatocellular carcinoma using machine learning and artificial neural networks and revealing the correlation by immunoassay
Shengke Zhang, Cheng‐Lu Jiang, Lai Jiang, et al.
Tumour Virus Research (2023) Vol. 16, pp. 200271-200271
Open Access | Times Cited: 45
Shengke Zhang, Cheng‐Lu Jiang, Lai Jiang, et al.
Tumour Virus Research (2023) Vol. 16, pp. 200271-200271
Open Access | Times Cited: 45
The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future
Yusuke Watanabe, Atsunori Tsuchiya, Shuji Terai
Clinical and Molecular Hepatology (2020) Vol. 27, Iss. 1, pp. 70-80
Open Access | Times Cited: 110
Yusuke Watanabe, Atsunori Tsuchiya, Shuji Terai
Clinical and Molecular Hepatology (2020) Vol. 27, Iss. 1, pp. 70-80
Open Access | Times Cited: 110
A Review of the Phytochemistry and Pharmacology of Phyllanthus urinaria L.
Madamanchi Geethangili, Shih‐Torng Ding
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 107
Madamanchi Geethangili, Shih‐Torng Ding
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 107
Development of Direct-acting Antiviral and Host-targeting Agents for Treatment of Hepatitis B Virus Infection
Yuchen Xia, T. Jake Liang
Gastroenterology (2018) Vol. 156, Iss. 2, pp. 311-324
Open Access | Times Cited: 103
Yuchen Xia, T. Jake Liang
Gastroenterology (2018) Vol. 156, Iss. 2, pp. 311-324
Open Access | Times Cited: 103
Inhibition of HBV Transcription From cccDNA With Nitazoxanide by Targeting the HBx–DDB1 Interaction
Kazuma Sekiba, Motoyuki Otsuka, Motoko Ohno, et al.
Cellular and Molecular Gastroenterology and Hepatology (2018) Vol. 7, Iss. 2, pp. 297-312
Open Access | Times Cited: 101
Kazuma Sekiba, Motoyuki Otsuka, Motoko Ohno, et al.
Cellular and Molecular Gastroenterology and Hepatology (2018) Vol. 7, Iss. 2, pp. 297-312
Open Access | Times Cited: 101
Advances in Targeting the Innate and Adaptive Immune Systems to Cure Chronic Hepatitis B Virus Infection
Zhongji Meng, Yuanyuan Chen, Mengji Lu
Frontiers in Immunology (2020) Vol. 10
Open Access | Times Cited: 92
Zhongji Meng, Yuanyuan Chen, Mengji Lu
Frontiers in Immunology (2020) Vol. 10
Open Access | Times Cited: 92
Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression
Arshi Khanam, Joel V. Chua, Shyam Kottilil
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5497-5497
Open Access | Times Cited: 91
Arshi Khanam, Joel V. Chua, Shyam Kottilil
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5497-5497
Open Access | Times Cited: 91
Mesenchymal stem cell therapies for liver cirrhosis: MSCs as “conducting cells” for improvement of liver fibrosis and regeneration
Atsunori Tsuchiya, Suguru Takeuchi, Takayuki Watanabe, et al.
Inflammation and Regeneration (2019) Vol. 39, Iss. 1
Open Access | Times Cited: 89
Atsunori Tsuchiya, Suguru Takeuchi, Takayuki Watanabe, et al.
Inflammation and Regeneration (2019) Vol. 39, Iss. 1
Open Access | Times Cited: 89
A rapid and sensitive recombinase aided amplification assay to detect hepatitis B virus without DNA extraction
Xinxin Shen, Fang-zhou Qiu, Liping Shen, et al.
BMC Infectious Diseases (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 86
Xinxin Shen, Fang-zhou Qiu, Liping Shen, et al.
BMC Infectious Diseases (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 86
When Hepatitis B Virus Meets Interferons
Guangyun Tan, Hongxiao Song, Fengchao Xu, et al.
Frontiers in Microbiology (2018) Vol. 9
Open Access | Times Cited: 85
Guangyun Tan, Hongxiao Song, Fengchao Xu, et al.
Frontiers in Microbiology (2018) Vol. 9
Open Access | Times Cited: 85
Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop
Hyung Joon Yim, Ji Hoon Kim, Jun Yong Park, et al.
Clinical and Molecular Hepatology (2020) Vol. 26, Iss. 4, pp. 411-429
Open Access | Times Cited: 85
Hyung Joon Yim, Ji Hoon Kim, Jun Yong Park, et al.
Clinical and Molecular Hepatology (2020) Vol. 26, Iss. 4, pp. 411-429
Open Access | Times Cited: 85
Guidelines for Prevention and Treatment of Chronic Hepatitis B
Guiqiang Wang, Zhongping Duan
Journal of Clinical and Translational Hepatology (2021) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 76
Guiqiang Wang, Zhongping Duan
Journal of Clinical and Translational Hepatology (2021) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 76
Small extracellular vesicles derived from interferon-γ pre-conditioned mesenchymal stromal cells effectively treat liver fibrosis
Suguru Takeuchi, Atsunori Tsuchiya, Takahiro Iwasawa, et al.
npj Regenerative Medicine (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 70
Suguru Takeuchi, Atsunori Tsuchiya, Takahiro Iwasawa, et al.
npj Regenerative Medicine (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 70
The Functions of Hepatitis B Virus Encoding Proteins: Viral Persistence and Liver Pathogenesis
Fenglin Zhao, Xiaoyu Xie, Xu Tan, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 58
Fenglin Zhao, Xiaoyu Xie, Xu Tan, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 58